A large-scale systematic survey of SARS-CoV-2 antibodies reveals recurring molecular features
Wang, Y.; Yuan, M.; Peng, J.; Wilson, I. A.; Wu, N. C.
Show abstract
In the past two years, the global research in combating COVID-19 pandemic has led to isolation and characterization of numerous human antibodies to the SARS-CoV-2 spike. This enormous collection of antibodies provides an unprecedented opportunity to study the antibody response to a single antigen. From mining information derived from 88 research publications and 13 patents, we have assembled a dataset of [~]8,000 human antibodies to the SARS-CoV-2 spike from >200 donors. Analysis of antibody targeting of different domains of the spike protein reveals a number of common (public) responses to SARS-CoV-2, exemplified via recurring IGHV/IGK(L)V pairs, CDR H3 sequences, IGHD usage, and somatic hypermutation. We further present a proof-of-concept for prediction of antigen specificity using deep learning to differentiate sequences of antibodies to SARS-CoV-2 spike and to influenza hemagglutinin. Overall, this study not only provides an informative resource for antibody and vaccine research, but fundamentally advances our molecular understanding of public antibody responses to a viral pathogen.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes 95%
- BCR, not TCR, repertoire diversity is associated with favorable COVID-19 prognosis 94%
- Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity 94%
Similar papers in this journal
- Structurally related but genetically unrelated antibody lineages converge on an immunodominantHIV-1 Env neutralizing determinant following trimer immunization 94%
- A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody 94%
- A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant 94%
Similar papers in this journal
- Widespread impact of immunoglobulin V gene allelic polymorphisms on antibody reactivity 97%
- Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza HA stem 94%
- Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple epitopes 94%
Similar papers in this journal
- Biochemical Patterns of Antibody Polyreactivity Revealed Through a Bioinformatics-Based Analysis of CDR Loops 95%
- Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies 94%
- A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1 93%
Similar papers in this journal
- AIRRscape: an interactive tool for exploring B-cell receptor repertoires and antibody responses 95%
- Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction 95%
- Comparison of sequence- and structure-based antibody clustering approaches on simulated repertoire sequencing data 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.